<DOC>
	<DOCNO>NCT00238576</DOCNO>
	<brief_summary>This project expand current knowledge reproductive biology woman bipolar disorder well assess impact lamotrigine use treatment bipolar disorder reproductive function . Specifically , study examines mood menstrual cycle ovulation three consecutive menstrual cycle woman treat bipolar I , II , NOS ( otherwise specify ) lamotrigine . In addition , testosterone lipid concentration measure participant start receive lamotrigine , well six month receive lamotrigine .</brief_summary>
	<brief_title>Lamotrigine Treatment Bipolar Disorder Women Reproductive Age</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Lamotrigine</mesh_term>
	<criteria>: Female Ages 18 45 Diagnosis bipolar disorder ( I , II , NOS ) Willing sign Human Subject Protection Consent Form prior enrollment study Willing use lamotrigine Never use lamotrigine prior study entry Unwilling unable comply study requirement , e.g . complete form , attend schedule evaluation Significant alcohol and/or substance abuse dependence within prior 6 month Used lamotrigine prior study entry , currently use lamotrigine study entry</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>December 2012</verification_date>
</DOC>